HIV vaccine candidate induces immune response in early clinical trial: ‘An important step forward’
Summary by Ground News
An experimental HIV vaccine has been found to induce broadly neutralizing antibodies among a small group of volunteers in a Phase 1 study. The findings suggest that a two-dose regimen of the vaccine, given eight weeks apart, can elicit immune responses against the human immunodeficiency virus.
Published 2 months ago · San Jose, United States
News Articles
More Filters
All
Left
Center
Right
Time & Location
Sources are mostly out of (0)
Bias Distribution
50% of the sources lean Left, 50% of the sources are Center
L 50%
C 50%
See less detail
